The government reduced the prices of 39 drugs, including cancer, diabetes and TB

There will also be relief in the treatment of covid

The price of a drug that protects against TB has been brought to a peak

New Delhi: The government has reduced the price of 39 commonly used medicines by changing the national list of essential medicines. The government has also reduced the prices of anti-cancer, anti-diabetic, anti-viral, anti-bacterial, anti-TB drugs and other drugs.

These drugs are also used in the treatment of corona. Experts working on the NLEM list have removed 16 such drugs from the list. The Indian Medical Research Council (IMRC) has been working for a long time to control the prices of medicines.

Commonly used drugs have now been brought to the price ceiling. These include the anti-sugar drug teneligliptin, the popular anti-TB drugs, and the covidar drug ivermectin, the totavirus vaccine, and others.

The government began researching the list of essential drugs, which was notified in 2015 and peaked in 2016. The Standing National Committee on Medicines was then tasked with compiling a list of which drugs should be made available in sufficient quantities and in sufficient quantities.

A committee headed by Health Research Secretary and ICMR Director Balram Bhargava, a senior official of the policy commission, another committee comprising the health secretary and the secretary of the pharmaceutical department sends such a list. The second committee decides which drugs should be brought under the price ceiling.